Scholarlink

Background <p>Tobacco chewing and smoking are major risk factors for oral cancer, with Oral Squamous Cell Carcinoma (OSCC), comprising approximately 90% of cases, especially in South-Central Asia. This study examines the early diagnostic value of salivary Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGFR) for OSCC in long-term chewers of tobacco.</p> Methods <p>This study assessed salivary EGF and EGFR concentrations by Enzyme-Linked Immunosorbent Assay (ELISA), in three groups: Healthy Controls (HC, <i>n</i> = 41), Tobacco Chewers with a 10-years history of tobacco use (TC, <i>n</i> = 41), and newly diagnosed OSCC patients (with tobacco chewing history of more than 10 years) with no prior history of neoplasms or anticancer treatment (OSCC, <i>n</i> = 19). All participants were over the age of 35.</p> Results <p>Salivary EGF levels were significantly reduced, while EGFR levels were elevated in tobacco chewers (TC) and newly diagnosed OSCC patients compared to healthy controls (HC), with no significant difference observed between TC and OSCC groups. Notably, the EGF: EGFR ratio demonstrated better diagnostic performance for OSCC in TC compared to EGF or EGFR alone. ROC analysis highlighted the potential of these biomarkers as diagnostic tools for OSCC in TC.</p> Conclusion <p>Salivary EGF: EGFR ratio may serve as an early diagnostic biomarker for OSCC in TC. Reduced EGF and elevated EGFR levels suggest their role in disease progression, warranting further large-scale studies for clinical validation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Salivary EGF: EGFR ratio as potential early diagnostic biomarker for oral cancer detection in tobacco chewers: a preliminary cross-sectional study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月29日

查看全文
  • Ruchika Kaul-Ghanekar,
  • Ravi S. Kharat,
  • Prerna Raina,
  • Amol Chaudhary,
  • Shraddha Walekar-Ghaisas

摘要

Background

Tobacco chewing and smoking are major risk factors for oral cancer, with Oral Squamous Cell Carcinoma (OSCC), comprising approximately 90% of cases, especially in South-Central Asia. This study examines the early diagnostic value of salivary Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGFR) for OSCC in long-term chewers of tobacco.

Methods

This study assessed salivary EGF and EGFR concentrations by Enzyme-Linked Immunosorbent Assay (ELISA), in three groups: Healthy Controls (HC, n = 41), Tobacco Chewers with a 10-years history of tobacco use (TC, n = 41), and newly diagnosed OSCC patients (with tobacco chewing history of more than 10 years) with no prior history of neoplasms or anticancer treatment (OSCC, n = 19). All participants were over the age of 35.

Results

Salivary EGF levels were significantly reduced, while EGFR levels were elevated in tobacco chewers (TC) and newly diagnosed OSCC patients compared to healthy controls (HC), with no significant difference observed between TC and OSCC groups. Notably, the EGF: EGFR ratio demonstrated better diagnostic performance for OSCC in TC compared to EGF or EGFR alone. ROC analysis highlighted the potential of these biomarkers as diagnostic tools for OSCC in TC.

Conclusion

Salivary EGF: EGFR ratio may serve as an early diagnostic biomarker for OSCC in TC. Reduced EGF and elevated EGFR levels suggest their role in disease progression, warranting further large-scale studies for clinical validation.